Stephan Bonnar and Josh Barnett , mixed martial arts (MMA) fighters from the UFC and PRIDE Fighting Championships , have also tested positive for the banned substance.  After the World Extreme Cagefighting show on January 20, 2006 Muay Thai turned MMA fighter Kit Cope also tested positive for boldenone.  Following the Strikeforce card on June 22, 2007 former PRIDE and UFC fighter Phil Baroni tested positive for boldenone, as well as stanozolol .  At a K-1 WGP event in Las Vegas on August 17, 2007 two fighters, Rickard Nordstrand and Zabit Samedov , both tested positive for boldenone.  Alexandre Franca Nogueira tested positive for boldenone in July 2008. 
DISCLAIMER: The information and recommendations set forth herein (hereinafter "Information") are presented in good faith and believed correct as of the date hereof. It is compiled from various sources and it is not necessarily all inclusive nor fully adequate in every circumstance. In addition, these suggestions should not be confused with nor followed in violation of applicable laws, regulations, rules or insurance requirements applicable. This MSDS sheet is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product. Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.
1. Winner, H. 1., and Rosalinde Hurley. Candida Albicans. Boston: Little, Brown, 1964.
2. Birdsall C. Gastrointestinal Candidiasis: Fact or Fiction Alt Med Rev 2(5) 346-354 1997
3. Knoke M. Clinical pictures of gastrointestinal candidiasis. Fiction or reality? Mycoses 39 Suppl 1:4043 1996.
4. Scheurlen M. Pathogenicity of fungi in the intestines – current status of the discussion. Fortschr Ned ;1 l4:3 19-321. 1996
5. Trier IS, Bjorkrnan DJ. Esophageal, gastric, and intestinal candidiasis. Ann J Med 71:39-43. 1984
6. Seelig, MS “Role of Antibiotic in the Pathogenesis of Candida Infections,” American Journal of Medicine, 40: 887-917 1966
7. Boero M, Pera A, et al: “Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with Hz-receptor antagonists.” Digestion 28:158-63,1983
8. Michael J. Kennedy MJ and Volz, PA “Ecology of Candida albicans Gut Colonization: Inhibition of Candida Adhesion, Colonization, and Dissemination from the Gastrointestinal Tract by Bacterial Antagonism,” Infection and Immunity, 49:654-663, 1985
9. Trowbridge JP and Walker M The Yeast Syndrome Bantam Books, New York, New York 1986
10. Truss C: The Missing Diagnosis Birmingham Alabama (The author) 1983
11. Crook WG: The Yeast Connection, A Medical Breakthrough 2nd Addition Professional Books, Jackson, TN, 1984
12. Crook, WG. The Yeast Connection and the Woman. Professional Books, Jackson TN 1987
13. Kroker GF: Chronic candidiasis and allergy. In, Broctoff J and Challacombe SJ (eds): Food Allergy and Intolerance WB Saunders, Philadelphia, PA,. 850-72, 1987
14. Iwata, K.; Yamamoto, Y “Glycoprotein Toxins Produced by Candida albicans.” Proceedings of the Fourth International Conference on the Mycoses, PAHO Scientific Publication #356, June 1977.
15 The Chronic Candidiasis Syndrome: Intestinal Candida and its relation to chronic illness OAM 1996-1997, 16. Gutierrez, J.; Maroto, C. et al: Circulating Candida antigens and antibodies: useful markers of candidemia. Journal of Clinical Microbiology. 31(9):25502, 1993.
17. Walsh, TJ.; Lee, JW.; et al: “Serum Darabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans.” Journal of Medical & Veterinary Mycology. 32(3):20515, 1994.